AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comSEP 122 min read$HNGE

Jim Cramer Explains Why He Added Hinge Health (HNGE) to His Fantasy Lineup

Hinge Health (HNGE) faces growth risks from economic downturns, acquisition integration, and competition. Hedge funds like Braidwell LP, Divisadero Street Capital, and Walleye Capital increased stakes. Jim Cramer highlights HNGE's growth potential, comparing it to a 'portfolio tight end.'

Original reporting
finance.yahoo.com
Published Sep 12, 2026, 11:01 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 13, 2026, 5:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Jim Cramer Explains Why He Added Hinge Health (HNGE) to His Fantasy Lineup — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$HNGENeutralLow
01

Why it matters

The piece offers a risk‑focused narrative without new data, suggesting cautious monitoring rather than immediate trading action.

02

Market read

Provides insight into Hinge Health's operational outlook and investor positioning, useful for sector analysts but low trading urgency.

03

What to watch

Potential for cost synergies and expanded service offerings could offset integration risks.

Relevance 4/10Novelty 2/10Timing: no specific timing

Background

Jim Cramer highlighted Hinge Health as a portfolio tight end, noting its growth prospects and recent strategic moves.

Company-level read

Ticker impact

$HNGENeutralMedium confidence
Context

The article discusses Hinge Health's recent $105M acquisition of Cylinder Health and notable hedge fund ownership, highlighting operational risks and investor interest.

Expected impact

Modest downside risk if integration issues materialize; limited upside without new growth catalysts.

Evidence & confidence

No fresh primary data; commentary recaps known facts, so impact is speculative.

Market effects

Sector

Highlights broader concerns for digital health firms facing integration and funding pressures.

Regional

Limited to U.S. healthcare technology sector.

Global

Minimal, as the story pertains to a single U.S.-listed company.

Counterpoint

What could challenge this read

Despite hedge fund interest, the acquisition may overextend resources, making the stock a short candidate.

Key entities

  • company
    Hinge Health, Inc.

    U.S.-listed digital health provider (ticker HNGE).

  • company
    Cylinder Health

    Target of Hinge Health's $105M cash acquisition.

Read at source← All news

Related articles

AUG 28
$HNGEHighAI 8/10

Could Hinge Health (HNGE) Stock Win as Digital Healthcare Expands Beyond MSK Care?

Hinge Health (NYSE:HNGE) raised its 2026 revenue guidance to $856M-$860M, up from $822.16M consensus. Q2 2026 revenue grew 53% YoY to $213M, with non-GAAP operating income doubling to $62M. The company announced a $105M acquisition of Cylinder Health and expanded its share repurchase program by $300M. Analysts RBC and Truist raised price targets to $110 and $112, respectively, citing strong growth and platform expansion.

finance.yahoo.com3 min
AUG 19
$HNGEMedAI 8/10

HNGE Stock Surges Nearly 90% YTD: Can Its Growth Story Continue?

Hinge Health (HNGE) stock has risen 90% YTD, outperforming industry and S&P 500. Q2 revenue grew 53% YoY to $213M, with 2026 guidance raised to $856-$860M. AI and automation improved margins, while new care programs expand market reach. Analysts project 2026 EPS of $2.50 and 2027 EPS of $3.29. Growth is driven by member yield, AI efficiency, and new care offerings, but execution risks remain.

zacks.com3 min
AUG 15
$HNGEMed

Jim Cramer says one stock hitting new highs is still a screaming buy

Jim Cramer reiterated a triple buy call on Hinge Health (HNGE) on “Mad Money” Aug. 11. The stock hit a new all-time high of $93.13 on Aug. 10 and is up about 85.83% YTD, per Yahoo Finance. Hinge reported Q2 2026 revenue of $213 million (+53% YoY), free cash flow of $99.6 million, and raised FY guidance to $856-$860 million. It also agreed to a $105 million cash acquisition (Cylinder Health) to expand into GI care.

yahoo.com6 min
AUG 12
$HNGEMed

Hinge Health (HNGE) Just Bought Its Way Into A New Market, So Now What?

Hinge Health (NASDAQ:HNGE) reported Q2 revenue of $213 million, up 53% year over year, above guidance of $200 million to $202 million. Gross margin rose to 87% and operating income to $62 million. The company said it used $105 million cash to acquire Cylinder Health for gastrointestinal care, while also expanding its migraine offering. It raised FY revenue guidance to $856 million to $860 million and authorized a $300 million buyback.

insidermonkey.com7 min
AUG 5
$HNGEHighAI 9/10

Why is Hinge Health stock surging today?

Hinge Health (HNGE) shares rose 11.6% after the company reported Q2 2026 revenue of $212.8M (+53% YoY) and non-GAAP diluted EPS of $0.59 vs $0.13 consensus. Free cash flow exceeded $100M. Hinge raised FY2026 revenue guidance to $818M-$824M and Q3 guidance to $223M-$225M, and agreed to buy Cylinder Health for $105M cash. Analysts lifted price targets.

investing.com4 min